http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2730955-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79ae6dd5bafbd2dd69035367385d754c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-00
filingDate 2019-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be66f6734efa875985862901aaa84254
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b845c030019f071350bddcf620b473c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5a62efc7a17098e9820b9474b1d60a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2270fe055e707ac533ac0700f773a17d
publicationDate 2020-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2730955-C1
titleOfInvention Method for reconstruction of the anterior cranial fossa base when performing block resection of a disseminated tumor of an anterior skull base
abstract FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to neurosurgery in surgical management of patients with anterior skull base with invasive growth and extracranial distribution. Split flap is formed from the convexital surface of the skull, the corresponding size of the anterior cranial fossa (ACF) defect. Slots are made on the sides of the bone flap. Subdurally artificial DM is placed in a defect of a dura mater (DM) of a cerebral base, artificial DM larger than a DM defect in size. Periosteal flap on the vascular pedicle formed earlier is laid on the ACF base. Splitted bone flap is laid over periosteal flap. Flap is fixed with slots in an ACF defect and enveloped with a periosteal graft. Sealing is performed by means of tachocomb and fibrin-thrombin adhesive. Thereafter, the DM defect is closed with using a flap pre-formed from a wide fascia of thigh.EFFECT: method enables avoiding prolapse of brain substance into extensive postresectional defect and development of corresponding neurological and infectious complications, higher clinical effectiveness.1 cl, 1 ex
priorityDate 2019-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2570619-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453035991

Total number of triples: 18.